# Actoplus Met

NDC: 64764-158
Generic name: pioglitazone and metformin hydrochloride
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20050829

FDA application: NDA021842

## Active ingredients

- METFORMIN HYDROCHLORIDE: 850 mg/1
- PIOGLITAZONE HYDROCHLORIDE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64764-158"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64764-158
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42e49120-6f3f-11db-9fe1-0800200c9a66